INSMED

INSMED

INSM· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +152.1% in FY2025

William H. Lewis is the CEO of INSMED and was paid $14.5M in FY2025 (Dec), up 32%.

Pay$100 in the stock at the end of FY20 → $523
CEO pay is from each INSMED proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1William H. LewisFY2025
  2. 2Martina Flammer, M.D.FY2025
  3. 3Roger AdsettFY2025
  4. 4Sara BonsteinFY2025
  5. 5Michael A. SmithFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

INSMED paid its 5 named executives $32.6M in total in FY2025 (Dec). CEO William H. Lewis was paid $14.5M of that.

Name
William H. LewisCEO
Martina Flammer, M.D.Chief Medical Officer
Roger AdsettChief Operating Officer
Sara BonsteinChief Financial Officer
Michael A. SmithChief Legal Officer6

of each named executive, from the Summary Compensation Table of each proxy.

Peers14

See all

The FY2023 (Dec) proxy of INSMED names 14 peer companies for pay. Pay versus performance data of INSMED for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board5

See all
  • David R. BrennanLead independent director · 9 yr on the boardIndependentCompensation (Chair)—Paid as an executive
  • Melvin Sharoky, M.D.Director · 22 yr on the boardIndependentNominations and Governance, Science and Technology—Paid as an executive
  • David W. J. McGirrDirector · 10 yr on the boardIndependentAudit (Chair)—Paid as an executive
  • Elizabeth McKee AndersonDirector · 5 yr on the boardIndependentNominations and Governance (Chair)—Paid as an executive
  • Clarissa Desjardins, Ph.D.Director · 4 yr on the boardIndependentScience and Technology (Chair)—Paid as an executive

The board of the latest proxy (FY2023).

Activity

  1. Pay
    INSMED CEO pay rose 32% to $14.5M. The stock rose 152% in FY2025 (Dec).
    DEF 14A
  2. Pay
    INSMED CFO pay rose 15% to $4.6M. The stock rose 152% in FY2025 (Dec).
    DEF 14A
  3. Pay
    INSMED COO pay rose 10% to $4.7M. The stock rose 152% in FY2025 (Dec).
    DEF 14A
  4. Pay
    INSMED Chief Medical Officer pay rose 15% to $4.7M. The stock rose 152% in FY2025 (Dec).
    DEF 14A
  5. Pay
    INSMED CEO pay rose 34% to $10.4M. The stock rose 55% in FY2023 (Dec).
    DEF 14A
  6. Pay
    INSMED CFO pay fell 12% to $4.0M. The stock rose 123% in FY2024 (Dec).
    DEF 14A
  7. Pay
    INSMED CFO pay rose 33% to $4.6M. The stock rose 55% in FY2023 (Dec).
    DEF 14A
  8. Pay
    INSMED COO pay fell 14% to $4.0M. The stock rose 55% in FY2023 (Dec).
    DEF 14A
  9. Pay
    INSMED COO pay rose 20% to $4.6M. The stock fell 27% in FY2022 (Dec).
    DEF 14A
  10. Pay
    INSMED Chief Medical Officer pay rose 12% to $4.2M. The stock rose 55% in FY2023 (Dec).
    DEF 14A

Filings6

See all
Proxy statementDEF 14AApr 1, 2026FY2025
Annual report10-KFeb 19, 2026FY2025
Proxy statementDEF 14AApr 4, 2025FY2024
Annual report10-KFeb 20, 2025FY2024
Proxy statementDEF 14AApr 1, 2024FY2023
Annual report10-KFeb 22, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data